Asensus Surgical Inc. buy krebskrebs
Start price
17.05.21
/
50%
€1.42
Target price
17.05.22
€2.00
Performance (%)
-73.34%
End price
18.05.22
€0.38
Summary
This prediction ended on 18.05.22 with a price of €0.38. Massive losses of -73.34% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Asensus Surgical Inc. | 3.394% | 3.394% | -60.400% |
iShares Core DAX® | 4.015% | 2.971% | 16.492% |
iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% |
iShares Nikkei 225® | -0.826% | -5.057% | 14.566% |
iShares S&P 500 | 2.330% | 0.720% | 30.194% |
Comments by krebskrebs for this prediction
In the thread Transenterix Inc diskutieren
Buy mit Kursziel 2,0
In the thread Trading Transenterix Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten